2022-04-19 2:09 pm
Development of gene or mRNA therapy for arrhythmogenic right ventricular cardiomyopathy (ARVC)
Proposed collaboration to develop ARVC therapies (e.g., gene therapy or mRNA therapy) using PKP2 mutant disease model cells from ARVC patients and corresponding recovery cells.